AGN-231868

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAGN-231868
Drug Alias NameAGN-231868
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCXC chemokine receptor antagonists
TargetsCXC chemokine receptor
Therapy Area/IndicationsDry Eye Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbbvie Inc
Inactive CompaniesN/A
Active IndicationsDry Eye Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A